Our results showed that CD34+CD38−CD26+ cells could be detected in 20 of the 22 patients, even though these patients had achieved UMRD for years, indicating that CML-LSCs could not be eliminated by TKIs (Figure 1A). Here, CD34 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.